Related Experiment Video
Updated: Jun 2, 2025
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient
Sandra Viz-Lasheras1,2,3,4, Alberto Gómez-Carballa1,2,3,4, Xabier Bello1,2,3,4
1Unidade de Xenética, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela, 15782, Calle San Francisco sn, Galicia, Spain.
Abstract:
Mycoplasma pneumoniae causes atypical pneumonia in children and young adults. Its lack of a cell wall makes it resistant to beta-lactams, which are the first-line treatment for typical pneumonia. Current diagnostic tests are time-consuming and have low specificity, leading clinicians to administer empirical antibiotics. Using a LASSO regression simulation approach and blood microarray data from 107 children with pneumonia (including 30 M. pneumoniae) we identify eight different transcriptomic signatures, ranging from 3-10 transcripts, that differentiate mycoplasma pneumonia from other bacterial/viral pneumonias with high accuracy (AUC: 0.84-0.95). Additionally, we demonstrate that existing signatures for broadly distinguishing viral/bacterial infections and viral/bacterial pneumonias are ineffective in distinguishing M. pneumoniae from viral pneumonia. The new signatures are successfully validated in an independent RNAseq cohort of children with pneumonia, demonstrating their robustness. The high sensibility of these signatures presents a valuable opportunity to guide the treatment and management of M. pneumoniae pneumonia patients.
Insights
New transcriptomic signatures accurately identify Mycoplasma pneumoniae pneumonia in children. These findings offer a promising tool for guiding antibiotic treatment and improving patient management for this common infection.
Area of Science:
- Pediatric infectious diseases
- Molecular diagnostics
- Respiratory medicine
Background:
- Mycoplasma pneumoniae causes atypical pneumonia, often requiring empirical antibiotic treatment due to diagnostic challenges.
- Beta-lactam antibiotics are ineffective against M. pneumoniae due to its lack of a cell wall.
- Current diagnostic methods for M. pneumoniae pneumonia are slow and lack specificity.
Purpose of the Study:
- To identify novel transcriptomic signatures for accurate diagnosis of M. pneumoniae pneumonia in children.
- To evaluate the efficacy of existing diagnostic signatures in differentiating M. pneumoniae from other pneumonias.
- To validate the newly identified signatures in an independent patient cohort.
Main Methods:
- Utilized LASSO regression simulation on blood microarray data from 107 children with pneumonia.
- Identified transcriptomic signatures (3-10 transcripts) distinguishing M. pneumoniae pneumonia.
- Validated the signatures in an independent RNAseq cohort.
Main Results:
- Eight novel transcriptomic signatures differentiated M. pneumoniae pneumonia with high accuracy (AUC: 0.84-0.95).
- Existing broad viral/bacterial pneumonia signatures were ineffective for M. pneumoniae detection.
- Validated signatures demonstrated robustness in an independent cohort.
Conclusions:
- Novel transcriptomic signatures offer a highly sensitive method for diagnosing M. pneumoniae pneumonia in children.
- These signatures can guide targeted antibiotic therapy, improving patient outcomes.
- The findings address a critical unmet need in pediatric respiratory infection diagnostics.
More Related Videos
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...